Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.8082
+0.0381 (4.95%)
At close: Feb 6, 2026, 4:00 PM EST
0.8000
-0.0082 (-1.01%)
After-hours: Feb 6, 2026, 6:09 PM EST
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $12.54 million as of February 6, 2026. Its market cap has increased by 10.78% in one year.
Market Cap
12.54M
Enterprise Value
4.70M
1-Year Change
10.78%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.39M to $12.54M, a decrease of -84.40%. That is a compound annual growth rate of -23.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 12.54M | -18.36% |
| Dec 31, 2025 | 15.36M | 166.64% |
| Dec 31, 2024 | 5.76M | -7.96% |
| Dec 29, 2023 | 6.26M | -38.29% |
| Dec 30, 2022 | 10.14M | -35.89% |
| Dec 31, 2021 | 15.82M | -50.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 13.21M |
| Kairos Pharma | 13.12M |
| Cellectar Biosciences | 13.08M |
| Curis | 13.04M |
| Moleculin Biotech | 12.75M |
| BioLineRx | 12.60M |
| KALA BIO | 12.51M |
| NewcelX | 12.26M |